Physician

Sterling L Cannon, M.D.

According to 2025 Medicare claims, Sterling Cannon, M.D. (NPI: 1447278106) practices ophthalmology in the Columbus, GA-AL market, with the plurality of this provider's patient population coming from Muscogee, GA. This provider's primary affiliated billing organization is WEST GEORGIA EYE CARE CENTER, PA (NPI: 1699868265; TIN: 581075293) and primary practice location at 31904-5323.

Cannon's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,107 traditional Medicare patients, billed 6,828 HCPCS/CPT codes, and received $342,921 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 933 prescription claims across 546 beneficiaries totaling $205,719 in drug costs, led by Xdemvy (Lotilaner). 2015 DME data shows 11 claims. Open Payments data shows 18 records totaling $726. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $107,060 to $205,719. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,124	5,914	$377,797
2016	1,184	7,332	$387,031
2017	1,240	7,406	$410,389
2018	1,264	7,386	$380,824
2019	1,123	6,543	$360,525
2020	1,035	6,294	$301,423
2021	1,114	6,888	$311,323
2022	1,154	6,607	$301,701
2023	1,149	7,470	$322,095
2024	1,107	6,828	$342,921

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	486	1,351	$107,060
2016	447	1,298	$124,362
2017	491	1,363	$132,925
2018	551	1,366	$115,940
2019	489	1,162	$122,533
2020	426	1,061	$125,290
2021	455	1,175	$167,001
2022	485	1,148	$195,913
2023	464	932	$128,056
2024	546	933	$205,719

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	11	11	$539
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	330	345	$83
92014	Established patient complete exam of visual system	462	579	$75
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	195	273	$59
92081	Exam of visual field with limited testing	248	252	$20
92285	Photography of content of eyes	435	472	$15

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xdemvy	Lotilaner	50	2,108	$97,232
Restasis	Cyclosporine	32	2,040	$41,185
Botox	Onabotulinumtoxina	35	3,150	$20,818
Cyclosporine	Cyclosporine	24	1,560	$20,494
Prednisolone Acetate	Prednisolone Acetate	86	1,809	$3,195

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	18	$726	Tarsus Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sterling L. Cannon, M.D.?

Tedicare shows public-source Medicare data for Sterling L. Cannon, M.D. (NPI 1447278106), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sterling L. Cannon, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Sterling L. Cannon, M.D.?

Sterling L. Cannon, M.D. is linked to WEST GEORGIA EYE CARE CENTER, PA (billing NPI 1699868265) in the available physician profile data.

Does Sterling L. Cannon, M.D. have Open Payments data?

Sterling L. Cannon, M.D. has 18 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.